Alzheimer disease: progress or profit?

This publication has 7 references indexed in Scilit:

• Public funding for Alzheimer disease research in the United States
  Nature Medicine, 2006
• Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
  Annals of Internal Medicine, 2005
• Current Treatment for Alzheimer Disease and Future Prospects
  Alzheimer Disease & Associated Disorders, 2003
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
  Nature Medicine, 2003
• Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050
  Alzheimer Disease & Associated Disorders, 2001
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease
  Neurology, 1995